These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 21491376

  • 1. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
    Alabed S, Latifeh Y, Mohammad HA, Rifai A.
    Cochrane Database Syst Rev; 2011 Apr 13; (4):CD000203. PubMed ID: 21491376
    [Abstract] [Full Text] [Related]

  • 2. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
    Soares K, Rathbone J, Deeks J.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD000203. PubMed ID: 15494993
    [Abstract] [Full Text] [Related]

  • 3. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
    Soares KV, McGrath JJ, Deeks JJ.
    Cochrane Database Syst Rev; 2001 Oct 18; (2):CD000203. PubMed ID: 11405955
    [Abstract] [Full Text] [Related]

  • 4. Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.
    Alabed S, Latifeh Y, Mohammad HA, Bergman H.
    Cochrane Database Syst Rev; 2018 Apr 17; 4(4):CD000203. PubMed ID: 29663328
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    Tammenmaa IA, McGrath JJ, Sailas E, Soares-Weiser K.
    Cochrane Database Syst Rev; 2002 Apr 17; (3):CD000207. PubMed ID: 12137608
    [Abstract] [Full Text] [Related]

  • 7. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    El-Sayeh HG, Rathbone J, Soares-Weiser K, Bergman H.
    Cochrane Database Syst Rev; 2018 Jan 18; 1(1):CD000458. PubMed ID: 29342497
    [Abstract] [Full Text] [Related]

  • 8. Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
    Bergman H, Soares-Weiser K.
    Cochrane Database Syst Rev; 2018 Jan 17; 1(1):CD000204. PubMed ID: 29341071
    [Abstract] [Full Text] [Related]

  • 9. Benzodiazepines for neuroleptic-induced tardive dyskinesia.
    Bhoopathi PS, Soares-Weiser K.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD000205. PubMed ID: 16855954
    [Abstract] [Full Text] [Related]

  • 10. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K, Rathbone J.
    Cochrane Database Syst Rev; 2006 Jan 25; (1):CD000459. PubMed ID: 16437425
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Benzodiazepines for neuroleptic-induced tardive dyskinesia.
    Umbrich P, Soares KV.
    Cochrane Database Syst Rev; 2003 Jan 25; (2):CD000205. PubMed ID: 12804389
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.
    Adelufosi AO, Abayomi O, Ojo TM.
    Cochrane Database Syst Rev; 2015 Apr 13; 2015(4):CD010501. PubMed ID: 25866243
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.